16 July 2020

An international consortium led by ATRO Medical, a spin-off of Radboudumc and DSM, will receive € 800,000 European funding for an innovation aimed at patients with knee osteoarthritis. These patients often suffer from cartilage wear due to a meniscus that no longer works properly. The consortium, which further consists of the Orthopaedic Research Laboratory (ORL) of the Radboudumc and the Swiss company Samaplast, will develop the first sustainable meniscus prosthesis to replace the outer meniscus.

Knee osteoarthritis is one of the major causes of disability worldwide. Loss of meniscus tissue in young years can accelerate this disease and lead to symptoms such as chronic knee pain, stiffness and restricted movement. For many patients, total knee replacement is ultimately the last resort. The Dutch orthopaedic startup ATRO Medical wants to create a solution for the years of pain that precedes a new knee.
  
Outer meniscus
The new meniscus prosthesis should serve as a new shock absorber in the knee, reducing bone-to-bone contact and reducing pain in the knee joint. A first version of this implant has been made for the inner meniscus. It is currently being tested in the first patients after ten years of research. However, there is still no solution for the outer meniscus. Forty percent of the complaints are related to problems with this outer meniscus.
  
Rapid development
The consortium of ATRO Medical, the Swiss company Samaplast and the Orthopaedic Research Laboratory (ORL) of the Radboudumc will receive €800,000 from EUROSTARS as a contribution to the total investment of €2 million to accelerate the development of this solution. Jan Hunik, CEO of Atro Medical: "The goal is to have this innovation ready for a clinical trial with patients within two years. Both the replacement of the worn out exterior meniscus by a wear-resistant plastic and the short development time of this project would be unique in the world of orthopaedics".
 
Expertise
Consortium partner ORL of the Radboudumc has been involved in meniscus research as a biomechanical expert for many years and was already part of the team that wrote the first patents for meniscus replacement. Dennis Janssen, head of experimental research at ORL: "After the earlier successful development of the inner meniscus prosthesis, this EUROSTARS grant gives us the opportunity to apply our expertise to the outer meniscus as well. This project is therefore a nice and logical continuation of our joint work".
 
Plastic
The Swiss partner Samaplast specialises in the manufacture of high quality and medical plastic products. Consortium leader ATRO Medical is a spin-off of the Radboudumc and DSM and focuses on the development of sustainable meniscus prostheses. Together, the parties have the expertise to quickly develop the new meniscus prosthesis with the EUROSTARS financing.


EUROSTARS supports international innovative projects led by R&D performing SMEs such as ATRO Medical. This EU programme aims to increase value creation within Europe, economic growth and employment.
ATRO Medical is a spin-off of DSM and Radboudumc with branches in Nijmegen and Oss (NL).

  • Want to know more about these subjects? Click on the buttons below for more news.

    Orthopedics

Related news items


Survey of patients to address knee pain from removed meniscus

19 November 2021 Patients with persistent knee pain after meniscus removal can participate at three locations in the Netherlands in the AIR2 study by ATRO Medical, a spin-off of the Radboudumc and DSM. read more

Phantomless calibration of CT scans for fracture risk assessment in cancer patients with femoral bone metastases

5 September 2019 In Plos One, Florieke Eggermont, Esther Tanck and colleagues developed a calibration method, which makes clinical implementation of CT-based finite element models as tool for fracture risk assessment easier. read more

€180k for Orthopaedic Research Laboratory

31 January 2019 Researchers of the Orthopaedic Research Laboratory of the Radboudumc, together with the LUMC, received a grant of €180k from the Innovatiefonds Zorgverzekeraars for clinical implementation of patient-specific computer models for fracture risk prediction in patients with bone metastases. read more

Philip van der Wees appointed Professor of Allied Health Sciences

30 May 2018 The focus of the Chair is value-driven allied health care in interdisciplinary networks. read more

Honorary doctorate in Aalborg for Nico Verdonschot

25 April 2018 Verdonschot has a global reputation in the field of orthopaedic biomechanics. Besides professor in the Radboudumc, he is the scientific director of the TechMed Centre, and professor of Biomechanical Implants at the department of Biomechanical Engineering at the UT. read more

ERC proof of concept grant Nico Verdonschot

20 February 2018 For the project BioMechMeniscus: A biomechanically driven, patient specific pre-planning and surgical tool to optimize placement of a novel meniscus prosthesis. read more